Vitamin D for treatment of non‐alcoholic fatty liver disease detected by transient elastography: A randomized, double‐blind, placebo‐controlled trial - Concepedia

Concepedia

Publication | Closed Access

Vitamin D for treatment of non‐alcoholic fatty liver disease detected by transient elastography: A randomized, double‐blind, placebo‐controlled trial

37

Citations

29

References

2020

Year

Vesna Lukenda Žanko, Viktor Domislović, Vladimir Trkulja, Irena Krznarić Zrnić, Tamara Turk Wensveen, Željko Krznarić, Tajana Filipec Kanižaj, Delfa Radić-Krišto, Lidija Bilić-Zulle, Lidija Orlić,

Diabetes Obesity and Metabolism

Abstract

Low-medium dose supplementation of vitamin D (1000 IU/day) over 12 months reduces TE indices of liver steatosis (CAP) and fibrosis (LSM) in NAFLD patients.

References

	Year	Citations

Page 1